https://orcid.org/0000-0002-1041-4202
Figures
Abstract
Background
Current knowledge of ocular manifestations of loiasis is limited to the transient subconjunctival passage of the adult filaria and anecdotal reports of posterior segment lesions. Therefore, the ocular burden of loiasis is likely underestimated since it has never been systematically assessed at the population level. We aimed to evaluate the relationship of Loa loa microfilaremia and recent eye worm passage with chronic ocular lesions identified through comprehensive ophthalmological assessment in an endemic area.
Methodology/principal findings
Subjects aged ≥ 15 years, residing in Akonolinga for ≥ 5 years, without filaricidal treatment for ≥3 years, were screened for filariases. After excluding participants with onchocerciasis lesions, a subset of randomly selected participants was assessed by ophthalmologists blinded to blood test results then allocated to four groups defined by microfilarial load (MFL) on calibrated thick blood film: G1 (Loa MFL = 0), G2 (MFL < 8000/mL), G3 (MFL ≥ 8000/mL), G4 (co-infestation with Mansonella MFL > 100/mL). The ophthalmological assessment comprised distance visual acuity, examination of the anterior segment with a slit lamp, and fundoscopy. The primary analysis consisted of univariable comparisons of the frequency of abnormal findings across four groups (G1 – 4) or two groups defined by history of eye worm passage. The secondary analysis consisted of a multivariable logistic regression analysis of the relationship of high Loa MFL (≥8000/mL) with chorioretinitis and eye worm passage with unilateral ametropia, adjusting for confounders. Of 1511 subjects screened, 200 underwent ophthalmological assessment, including 65, 69, 35, and 16 in G1 to 4. History of eye worm passage in the previous year was reported by 121 participants (65.4%). Unilateral ametropia was more prevalent in people with history of eye worm passage in the previous year (26.5% versus 10.9%, p = 0.014). Chorioretinitis was the most frequent posterior segment lesion (n = 11, 6.1%) and was most prevalent in G3 (14.3%). The frequency of chorioretinitis was higher in participants with moderate-to-severe visual impairment (27.3% versus 4.4%, p = 0.002). High Loa MFL was an independent predictor of chorioretinitis (adjusted OR=5.28; p = 0.01). History of eye worm passage in the previous year was independently associated with unilateral ametropia (adjusted OR=3.27, p = 0.0088).
Conclusions/significance
This study has, for the first time, provided evidence of independent association between history of eye worm passage and unilateral ametropia, and between high Loa MFL and severe chorioretinal lesions. This suggests that loiasis should be classified as a neglected tropical disease.
Author summary
Loiasis is endemic in Western and Central Africa and affects more than 10 million individuals. Currents knowledge of its ocular manifestations is limited to the transient subconjunctival passage of the adult worm and anecdotal case reports of severe lesions such as optic neuritis and retinal hemorrhage. Consequently, loiasis has repeatedly failed to meet WHO’s morbidity and mortality criteria for inclusion in the strategic plan for neglected tropical diseases. We aimed to provide additional evidence to support this inclusion by studying the relationship of Loa loa microfilaremia and recent eye worm passage with chronic ocular lesions by performing a systematic ophthalmological assessment of community-dwelling adults in an endemic area. For the first time, we provide evidence that, contrary to prior knowledge, severe ocular lesions such as chorioretinitis are highly prevalent (14.3%) in people with high Loa loa microfilarial loads (MFL) and significantly associated with moderate-to-severe visual impairment. Specifically, people with a high MFL (>8000 mf/mL) are 5 times more likely to have chorioretinitis than those with low MFL or without infestation, independent of age, sex, co-infestation with other filaria, and cardiovascular risk factors. We also report that people with recent eye worm migration were 3 times more likely to have unilateral ametropia. Our findings contradict perceptions that loiasis is a benign disease and suggest that it should be classified as a neglected tropical disease. Such reclassification will boost the design and funding of cost-effective public health strategies to eliminate loiasis.
Citation: Kamgno J, Kamtchum-Tatuene J, Esso L, Eyebe-Eyebe SB, Kagmeni G, Bopda J, et al. (2025) A cross-sectional investigation of the ophthalmological impact of loiasis in Cameroon, Central Africa. PLoS Negl Trop Dis 19(6): e0013216. https://doi.org/10.1371/journal.pntd.0013216
Editor: Feng Xue, Zhejiang Wanli University, CHINA
Received: March 25, 2025; Accepted: June 6, 2025; Published: June 26, 2025
This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Data Availability: Anonymized individual participant data necessary to reproduce our results are provided in the Supporting Information files.
Funding: This study was funded by the Mectizan Donation Program as part of the annual budget allowance (to JK) and the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health (to AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: I have read the journal's policy and the authors of this manuscript have the following competing interests: Dr. Adrian Hopkins was Director of the Mectizan Donation Programme from 2008 to 2016. Prof. Joseph Kamgno reports no conflicts of interest. Dr. Joseph Kamtchum-Tatuene reports no conflicts of interest. Dr. Linda Esso reports no conflicts of interest. Dr. Eyebe Eyebe Serge Bertrand reports no conflicts of interest. Dr. Giles Kagmeni reports no conflicts of interest. Mr. Jean Bopda reports no conflicts of interest. Dr. Jean Tenaguem reports no conflicts of interest. Prof. Amy Klion reports no conflicts of interest. Dr. Hugues Nana-Djeunga reports no conflicts of interest. Prof. Lucienne Bella-Assumpta reports no conflicts of interest.
Introduction
Loiasis is an African parasitic infection caused by the filarial nematode Loa loa and transmitted to humans by an insect vector called Chrysops [1,2]. It affects more than 10 million individuals and is associated with significant morbidity and mortality [3,4]. It is responsible for various systemic manifestations resulting from dermatologic [5–7], cardiac [8], renal [9], neurologic [10], gynecologic [11,12], and ophthalmological lesions [4,13]. Ocular manifestations described to date include orbital lesions caused by macrofilariae and posterior segment lesions caused by microfilariae. Anterior lesions refer to either the subconjunctival passage of the adult worm or orbital oedema, which both irritate but are not especially painful, the asymptomatic presence of an adult worm in the anterior chamber, or filarial uveitis [14]. Posterior segment lesions comprise retinal blood vessel embolism by microfilariae in people with high microfilarial loads [15], neuro-chorio-retinal lesions [16], retinal detachment [17], and retinal exudates or hemorrhages that occur spontaneously or as a consequence of antifilarial treatment [18].
Despite the manifestations described above, loiasis is generally considered a benign disease and is, therefore, neglected by health policy makers in endemic countries [7]. Loiasis is not even mentioned among neglected tropical diseases [19], which is likely a consequence of an underestimation of the true burden of its complications. Indeed, current knowledge of ocular manifestations of loiasis is mostly derived from case series or anecdotal case reports and no prior study has performed a systematic comprehensive ophthalmological assessment of community-dwelling individuals to detect chronic eye lesions potentially attributable to loiasis.
To bridge the knowledge gap, we aimed to determine the relationship between clinical and biological features of loiasis (eye worm passage, microfilarial load) and chronic ocular lesions in adults residing in a loiasis-endemic area. We hypothesized that eye lesions would be more prevalent in people with loiasis irrespective of their microfilarial load, that there would be a dose-response effect as a higher infestation burden could cause higher levels of systemic inflammation or higher risk of microvascular damage, and that co-infestation with Mansonella perstans could aggravate the deleterious effects of loiasis.
Patients and methods
Ethics statement
The study was approved by the Cameroon National Ethics Committee for Human Research (authorization number 044/CNE/MP/08), and participation was subject to signature of a written informed consent. For participants aged <18 years old, the written informed consent was obtained from the parent or legal guardian.
Study site, design, and approval
This study was conducted in the Akonolinga Health District, which is located in the Centre Cameroon Forest approximately 100 km from the capital city Yaounde. The study site was chosen because it was predicted to be endemic for loiasis [20] and known to be hypo-endemic for onchocerciasis based on the rapid epidemiological mapping of onchocerciasis performed in 1997 [21]. These criteria were used to minimize onchocercal eye disease as a confounding factor when studying the relationship between ocular lesions and Loa loa microfilarial load.
The study comprised a screening phase, during which participants were assessed and selected based on their Loa loa microfilarial load, and a clinical phase focusing on comprehensive ophthalmological examination.
Phase 1: Screening for filariases.
All subjects aged 15 years and above, residing in the study area for at least five years, with no history of filaricidal treatment over the preceding three years, were invited to participate in the study. Communication about the study was performed several weeks prior to enrolment with the help of local authorities and community leaders. People willing to take part in the study were instructed to gather at one of five enrolment sites prepared by our research team in five out of 11 villages of the Akonolinga Health District, namely Abem, Edjom, Endom, Ekoudou, and Yeme Yeme. These villages were selected by random number generation. Enrolment sites were prepared either at the local health facility or at the village chief’s residence.
For each participant, we performed an interview, a physical examination, and a calibrated thick blood film. The interview aimed to collect demographic data (age, sex, place of birth, village of residence); successive places of residence since birth, and a history of prior symptoms consistent with loiasis (pruritus, Calabar swelling, subconjunctival L. loa, headache, arthralgia). The physical examination was performed by two experienced clinicians to identify lesions of onchocerciasis or lymphatic filariasis such as onchocercal nodules, hydrocele, and lymphoedema of the limbs, also called elephantiasis. Participants were also screened for hypertension and diabetes mellitus. Hypertension was defined as blood pressure > 140/90 mmHg on either or both arms [22]. Diabetes mellitus was defined as fasting blood glucose > 1.26 g/L.
The calibrated thick blood film (CTBF) was performed between 11 a.m. and 3 p.m. using whole blood freshly drawn using 70-µL non-heparinized microhematocrit capillary tubes. Thick blood smears were prepared by spraying 50 µL of whole blood on a glass slide to form a rectangle of 3 by 2 centimeters. The smears were dried, dehemoglobinized for 10–15 minutes using buffered water, fixated with methanol, then stained for 30 minutes with Giemsa solution diluted 1/10. After further rinsing and drying, slides where read under a microscope (10X objective) to identify and count microfilariae of Loa loa (270–300 µm by 6–8 μm, sheathed, tapered tail with nuclei extending to the tip) and Mansonella perstans (smaller, 180–240 µm by 3–5 μm, and unsheathed). All slides were read by two experienced parasitologists at the laboratory of the Higher Institute for Scientific and Medical Research, Yaounde, Cameroon. In case of discrepancy, a third independent reader was involved.
Phase 2: Ophthalmological assessment.
After excluding participants with onchocercal nodules or lesions of lymphatic filariasis, and those who had resided in an area endemic for onchocerciasis for at least two years, 200 subjects were randomly selected to undergo an ophthalmological examination by consultant ophthalmologists blinded to CTBF results. The random sampling without replacement from the screening dataset was performed with SPSS 12.0 (International Business Machines Corporation, New York, USA).
The ophthalmological examination comprised (i) assessment of distance visual acuity using an E illiterate chart and a pin hole for gross correction in patients with visual acuity less than 1, (ii) examination of the anterior segment of the eye using a portable slit lamp (Kowa Company Ltd, Nagoya, Japan), and (iii) examination of the posterior segment of the eye using either a slit lamp with an indirect 78-diopter lens (Volk optical inc., Ohio, USA) or an ophthalmoscope (HEINE Optotechnik GmbH, Gilching, Germany). Ophthalmological examinations were conducted in health centers or in a dedicated room provided by a community leader. In this field epidemiology study, refractive error was defined as a visual acuity less than 10/10 in at least one eye that improves by at least 1 point after using the pinhole. Moderate-to-severe visual impairment was defined as best corrected visual acuity less than 3/10 for both eyes, as per the World Health Organization criteria [23].
All participants diagnosed with retinal lesions underwent retinal angiography and a skin snip test to rule out onchocerciasis. All angiographies were performed at the Ophthalmology Unit of the Yaounde Central Hospital, while the skin snip tests were performed by experienced biologists at the Higher Institute for Scientific and Medical Research.
Data analysis
Categorical and continuous data were summarized as count (proportion) or median (range) unless otherwise stated.
In the primary analysis, we performed various comparisons between four groups defined by CTBF results to investigate the ophthalmological impact of loiasis and the potential modulating effect of the co-infestation with Mansonella perstans (Fig 1). Group 1 comprised participants with negative CTBF. Participants with mono-infestation by Loa loa were assigned to Group 2 (low microfilarial load, i.e., < 8000 microfilariae of Loa loa per milliliter of blood, mf/mL) or Group 3 (high microfilarial load, ≥ 8000 mf/mL). The threshold of 8000 mf/ml was chosen because patients harboring more than 8000 L. loa mf/ml are at higher risk of severe adverse reactions after treatment by ivermectin [24]. Group 4 comprised participants co-infested with L. loa and M. perstans with at least 100 mf/ml of M. perstans (substantial co-infestation). Participants with mono-infestation by Mansonella perstans and those with non-substantial co-infestation (less than 100 mf/ml of M. perstans irrespective of their Loa loa microfilarial load) were excluded from the primary analysis (n = 15). Participants were considered positive for a given anterior or posterior segment condition if characteristic lesions were observed in either or both eyes. We also performed additional analysis to identify factors associated with eye worm passage and explore its potential consequences on eye health. Fisher’s exact test was used to compare proportions of participants with a specific clinical, biological or ophthalmological condition between groups defined by microfilarial load of Loa loa and Mansonella perstans or by history of eye worm passage. Kruskal-Wallis test was used to compare medians of continuous parameters between groups.
CTBF: Calibrated thick blood film, MFL: microfilarial load (mf/mL).
In the secondary analysis, that included all participants in Phase 2, we performed a multivariable binary logistic regression analysis of the association between chorioretinitis and high microfilarial loads of Loa loa (≥8000 mf/mL irrespective of the co-infestation with Mansonella perstans), while adjusting for age (continuous), sex, hypertension, diabetes mellitus, tobacco consumption, history of eye worm passage during the previous year, and presence of infestation by Mansonella perstans. We also performed a multivariable binary logistic regression analysis of the association between history of eye worm passage during the previous year and unilateral ametropia, while adjusting for high microfilarial loads of Loa loa, age (continuous), sex, hypertension, diabetes mellitus, tobacco consumption, and presence of infestation by Mansonella perstans. In the multivariable regression analyses, all variables listed above were forced into the model and no a priori selection was applied because our aim was not to build a perfect prediction model for chorioretinitis or unilateral ametropia, but rather to test if their respective association with high Loa loa microfilarial load or history of eye worm passage is robust to the adjustment for all potential confounders. Variables were only excluded in case of collinearity, that is if they were perfect combinations of one another. The significance of individual regression coefficients was determined by a Wald test. The goodness of fit of the multivariable regression model was assessed with the Hosmer-Lemeshow chi-squared test. The model performance was assessed by the percent explained variance (R2); the model calibration by calculating the proportion of observations correctly classified, and the model discrimination by computing the area under the receiver operating characteristic curve (AUC).
Sensitivity analyses were performed to verify the specificity of the association between high Loa loa microfilarial load and chorioretinitis. First, we refitted the multivariable logistic regression with Loa loa microfilaremia as the primary independent variable while adjusting for presence of infestation with Mansonella perstans, age (continuous), sex, hypertension, diabetes mellitus, tobacco consumption, and history of eye worm passage during the previous year. Second, we refitted the multivariable logistic regression with any microfilaremia as the primary independent variable while adjusting for Loa-Mansonella coinfestation, age (continuous), sex, hypertension, diabetes mellitus, tobacco consumption, and history of eye worm passage during the previous year.
All statistical tests were two-sided, and the significance threshold was defined as p ≤ 0.05. Data were analyzed with SPSS 12.0 (International Business Machines Corporation, New York, USA).
Results
We screened 1511 subjects (median age: 50 years, range: 15.0 – 91.0), and performed ophthalmological assessment in a subset of 200 randomly selected participants including 65 in Group 1, 69 in Group 2, 35 in Group 3 and 16 in Group 4 (Fig 1 and Table 1). Fundoscopy was not possible in nine subjects due to bilateral lens opacity (three in Group 1, one in Group 2, one in Group 4, two with M. perstans mono-infestation, and two with non-substantial co-infestation). Among participants undergoing ophthalmological assessment, 44 patients had a high microfilarial load of Loa loa including 35 with Loa loa mono-infestation (Group 3), six with substantial co-infestation (Group 4), and three with non-substantial co-infestation (excluded from the primary analysis). Fundoscopy was not possible in 2 subjects with high microfilarial load due to bilateral lens opacity (one in Group 4 and one with non-substantial co-infestation).
In the primary analysis, 121 participants (65.4%) had had at least one episode of eye worm passage during the year preceding the study and 18 participants (9.7%) reported having 10 episodes or more, with no difference between the four groups defined by presence and density of microfilaremia (Table 1). Unilateral ametropia was more prevalent in people with a history of eye worm passage in the previous year (26.5% versus 10.9%, p = 0.014, Table 2). There was a trend towards a higher number of participants with more than 10 episodes of eye worm passage in the previous year in people with unilateral ametropia (41.2% versus 19.1%, p = 0.055). None of the patients with ametropia (unilateral or bilateral) had visual impairment.
There was no difference in the frequency of refractive errors, moderate-to-severe visual impairment, and anterior segment lesions between the four groups defined by presence and density of microfilaremia (Table 3). Chorioretinitis was the most frequent lesion on posterior segment examination (11 cases, 6.1%), and it was more prevalent in group 3 versus groups 1, 2, and 4 (14.3% versus 8.1%, 0%, and 6.7%; p = 0.01) (Table 3). There was only a 7% power to detect the nearly two-fold difference in frequency of chorioretinitis between group 3 and group 1. Chorioretinitis was bilateral in 4 cases, including 3 in group 3 and 1 in group 4. Bilateral chorioretinitis was more frequent in group 3 versus group 1 (8.6% versus 0.0%, p = 0.044), and significantly more prevalent in people with high versus low Loa loa microfilarial load (9.5% versus 0.0%, p = 0.0021). None of the retinal lesions found had the characteristics of toxoplasmic chorioretinitis. There were no cases of moderate-to-severe visual impairment or chorioretinitis in participants excluded from the primary analysis.
The biological characteristics of participants with chorioretinitis are presented in Table 4. Two of them had possible concomitant onchocerciasis with 2 and 0.5 mf per skin biopsy, while only one had co-infestation with Loa loa and Mansonella perstans. Angiography results for the 47-year-old female participant with chorioretinitis who had the highest Loa loa microfilarial load are presented in Fig 2. The distribution of the other posterior segment lesions did not differ between the groups. Only one case of retinal hemorrhage was found in a 69-year-old nondiabetic male with a Loa loa microfilarial load of 11380 mf/ml. He was also found to have stage II high blood pressure (207/98 mmHg).
Right eye is shown in the left column and left eye in the right column. Color fundus photographs (A, B), green light photographs (C, D), and late-phase fluorescein angiogram (E, F) show large macular chorioretinal scar with central presumed subfoveolar fibrosis (red stars), concentric areas of abnormal retinal pigment epithelium in the posterior pole (blue arrowheads), peripheral retinal pigment epithelium atrophy (yellow stars), and diffuse vascular thinning.
In the secondary analysis, the frequency of chorioretinitis was higher in participants with moderate-to-severe visual impairment (27.3% versus 4.4%, p = 0.018), and in participants with a Loa loa microfilarial load >8000 mf/mL (14.3% versus 3.4%, p = 0.016). In the multivariable binary logistic regression, a high microfilarial load of Loa loa was the single independent predictor of chorioretinitis (adjusted OR=5.28; 95% CI: 1.42-19.57, p = 0.013, Table 5). In the sensitivity analyses, there was no association between chorioretinitis and Loa loa microfilaremia or any microfilaremia (S1 and S2 Tables). A history of eye worm passage in the previous year was independently associated with unilateral ametropia (adjusted OR=3.27, 95% CI: 1.35-7.93, p = 0.0088, Table 6).
Discussion
This study provides evidence that high microfilarial loads of Loa loa are independently associated with chorioretinitis lesions, suggesting that onchocerciasis is not the only filariasis responsible for visual impairment. Indeed, we made reasonable efforts to exclude cases of onchocerciasis by (i) selecting a study site not endemic for onchocerciasis, (ii) excluding participants harboring onchocercal nodules, and (iii) excluding people who lived in an area endemic for onchocerciasis for two years or more. We did not find microfilariae of O. volvulus on slit lamp examination of the anterior segment in any of the subjects selected for the second phase of the study. Moreover, we did not find lesions suggestive of ocular onchocerciasis such as uveitis, sclerosing keratitis, peripapillary ring-shaped atrophy with hypo-autofluorescence, and macula-sparing pigment epithelial atrophy affecting the temporal and nasal retina [25–27]. Findings of other epidemiological studies in Central Africa also support the potential contribution of loiasis to posterior segment lesions. For instance, in Ogooué-Lolo province in Gabon, a region hypoendemic for onchocerciasis (7%), Fobi et al. reported a low prevalence of anterior segment lesions and a high prevalence of optic nerve (5.2%) and chorio-retinal lesions (2.7%) [28], which could be related to the high prevalence of loiasis (27.9%) [29].
Among participants with chorioretinal lesions, only two were found to have positive skin snip tests with very low onchocercal microfilarial loads. Both subjects also had very high loads of Loa loa microfilariae (44540 and 67840 mf/mL), which could have been detected on the skin snip tests leading to the positive results, as previously described [30]. The chorioretinal lesions observed on fundoscopy could be scars of repeated retinal hemorrhages or after-effects of microembolisation of retinal blood vessels by microfilariae in cases of massive infestation [15]. Indeed, the unique case of retinal hemorrhage was reported in a participant with a high microfilarial load (11380 mf/mL), albeit there was a concurrent diagnosis of stage II high blood pressure. Although the reported chorioretinal lesions have some overlapping features with geographical atrophy seen in age-related maculopathy, the lack of association with age and cardiovascular risk factors makes the diagnosis unlikely, especially in participants younger than 50 years [31,32].
A history of eye worm passage was highly frequent in our study population. In 2002, Takougang et al. carried out a survey simultaneously in Cameroon and Nigeria and demonstrated that a 40% prevalence of history of eye worm passage corresponds to a 20% prevalence of Loa loa microfilaremia [33]. The results obtained in the Akonolinga health district are, therefore, consistent with the conclusions of their study, since we found a 23% prevalence of Loa loa microfilaremia [34]. There was no difference between study groups with respect to the frequency of a history of eye worm passage, which confirms the low sensitivity of CTBF as a diagnostic tool for loiasis [35,36]. It also emphasizes the absence of a relationship between Loa loa microfilarial load and the frequency of eye worm passages. Indeed, we also found no difference between the groups with respect to the mean annual number of eye worm passages per individual. This is explained, at least in part, by the fact that the number of adult worms is independent of the Loa loa microfilarial load [6,37].
We report an independent association between eye worm passage in the previous year and unilateral ametropia. The underlying reason for this association is not straightforward and it may be a chance finding. However, one could hypothesize that the eye worm passage induces an edema of periorbital and ocular tissues, especially the cornea. This edema alters the refractive properties of the affected eye resulting in unilateral ametropia. In theory, the ametropia would be transient, resolving when the edema disappears, and leaving no permanent effect on visual acuity [4,38]. But it is possible that repeated passages induce more permanent or irreversible damage. This hypothesis would align with the reported trend towards a higher number of participants with more than 10 episodes of eye worm passage in the previous year among individuals with unilateral ametropia. Unfortunately, we could not explore this further in our data analysis because we did not record the side of the most recent eye worm passage to check if it matches the side of the ametropia and the time elapsed since the event to assess if a certain degree of edema was likely to be present. Moreover, we did not follow participants to ascertain if some cases of ametropia would be reversible. Further studies are, therefore, needed to confirm our findings.
Despite the large sample size and the robust methodology used to establish the ophthalmological impact of loiasis, our study has some limitations. First, most patients with loiasis are amicrofilaremic and Giemsa-stained thick blood smear has low diagnostic sensitivity in individuals with low microfilarial loads [39,40]. Therefore, it is possible that some individuals with very low microfilarial loads were misclassified in group 1, thus leading to attenuation of the association between loiasis and choriretinitis. Using polymerase chain reaction-based assays could have increased our statistical power by limiting the extent of such potential classification bias. Unfortunately, molecular tests were not affordable at the time of the study. Moreover, we did not perform a molecular test on the microfilariae identified on skin snip tests and could not test for IgG4 antibodies against Onchocerca volvulus-specific antigen Ov16 to formally rule out any history of onchocerciasis in people with chorioretinal lesions [30,41]. Therefore, although the probability of onchocerciasis is low, it remains possible that some cases of chorioretinitis identified were attributable to onchocerciasis. Second, we did not assess color vision during the ophthalmological examination and cannot comment on either the potential relationship of loiasis with impaired color vision or the consequences of the observed chorioretinal lesions on color vision in affected subjects. Third, we did not perform optical coherence tomography to further characterize the retinal lesions and better understand the potential underlying pathobiological mechanism. Fourth, we did not collect longitudinal data to assess the incidence of new chorioretinal lesions in people with high microfilarial loads versus controls as well as the evolution of refraction errors. Consequently, further studies are needed to confirm the link between loiasis, chorioretinal lesions and visual impairment.
In conclusion, this is the first study performing a systematic ophthalmological assessment of community-dwelling adults to provide evidence that, contrary to previous knowledge, loiasis is associated with chronic ophthalmological lesions that could lead to visual impairment. This supports the idea that loiasis should be classified as a neglected tropical disease. Novel efficient and cost-effective public health strategies to eliminate loiasis are, therefore, urgently needed.
Supporting information
S1 Table. Univariable and multivariable analysis of factors associated with chorioretinitis using any microfilaremia as the main independent variable.
https://doi.org/10.1371/journal.pntd.0013216.s001
(PDF)
S2 Table. Univariable and multivariable analysis of factors associated with chorioretinitis using Loa loa microfilaremia as the main independent variable.
https://doi.org/10.1371/journal.pntd.0013216.s002
(PDF)
S1 Data Dictionary. Explanatory table for the variables included in the database.
https://doi.org/10.1371/journal.pntd.0013216.s003
(PDF)
Acknowledgments
We are grateful to the populations of the Akonolinga health District who took part in this study. We are also grateful to Prof Charles Mackenzie who contributed to the elaboration of the study protocol. We appreciate the help of the District Medical officer of the Akonolinga Health District, Dr Sihom. We pay homage to Dr. Patrick Ella, MD, a Consultant Ophthalmologist involved in the study who sadly passed away a few years ago.
References
- 1. Boussinesq M, Gardon J. Prevalences of Loa loa microfilaraemia throughout the area endemic for the infection. Ann Trop Med Parasitol. 1997;91(6):573–89. pmid:9425360
- 2. Cox FEG. History of human parasitology. Clin Microbiol Rev. 2002;15(4):595–612. pmid:12364371
- 3. Chesnais CB, Takougang I, Paguélé M, Pion SD, Boussinesq M. Excess mortality associated with loiasis: a retrospective population-based cohort study. Lancet Infect Dis. 2017;17(1):108–16. pmid:27777031
- 4. Ramharter M, Butler J, Mombo-Ngoma G, Nordmann T, Davi SD, Zoleko Manego R. The African eye worm: current understanding of the epidemiology, clinical disease, and treatment of loiasis. Lancet Infect Dis. 2024;24(3):e165–78. pmid:37858326
- 5. Carme B, Mamboueni JP, Copin N, Noireau F. Clinical and biological study of Loa loa filariasis in Congolese. Am J Trop Med Hyg. 1989;41(3):331–7. pmid:2679158
- 6. Noireau F, Apembet JD, Nzoulani A, Carme B. Clinical manifestations of loiasis in an endemic area in the Congo. Trop Med Parasitol. 1990;41(1):37–9. pmid:2339244
- 7. Takougang I, Meli J, Lamlenn S, Tatah PN, Ntep M. Loiasis--a neglected and under-estimated affliction: endemicity, morbidity and perceptions in eastern Cameroon. Ann Trop Med Parasitol. 2007;101(2):151–60. pmid:17316501
- 8. Bukhman G, Ziegler J, Parry E. Endomyocardial fibrosis: still a mystery after 60 years. PLoS Negl Trop Dis. 2008;2(2):e97. pmid:18301727
- 9. Pakasa NM, Nseka NM, Nyimi LM. Secondary collapsing glomerulopathy associated with Loa loa filariasis. Am J Kidney Dis. 1997;30(6):836–9. pmid:9398129
- 10. Boussinesq M, Gardon J, Gardon-Wendel N, Kamgno J, Ngoumou P, Chippaux JP. Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis. Am J Trop Med Hyg. 1998;58(4):461–9. pmid:9574793
- 11. Callihan TR, Oertel YC, Mendoza M. Loa loa in a gynecologic smear. Am J Trop Med Hyg. 1977;26(3):572–3. pmid:266848
- 12. Languillat G, Garin Y, Tursz A, Beauvais B, Lariviére M. Etiological study of low fertility in eastern Gaboon. III. Filarial endemicity (Loa loa, D. perstans). Prevalence of microfilariae in hydroceles (author’s transl). Rev Epidemiol Sante Publique. 1977;26(3):273–82. pmid:570721
- 13. Eballe AO, Epée E, Koki G, Owono D, Mvogo CE, Bella AL. Intraocular live male filarial Loa loa worm. Clin Ophthalmol. 2008;2(4):965–7. pmid:19668454
- 14. Choyce DP. Uveitis in tropical ophthalmology. Trans Ophthalmol Soc U K (1962). 1976;96(1):145–7. pmid:1070844
- 15. Corrigan MJ, Hill DW. Retinal artery occlusion in loiasis. Br J Ophthalmol. 1968;52(6):477–80. pmid:5665947
- 16. Popescu MP, Paun L, Panaitescu D. Neuro-chorio-retinal manifestations in Onchocerca volvulus and Loa loa filariasis associated with malaria. Bull Mem Soc Fr Ophtalmol. 1986;97:54–6. pmid:3539248
- 17. Cârstocea B, Pintiliei E. Ocular filariasis with retinal detachment. Oftalmologia. 1993;37(3):210–4. pmid:8338821
- 18. Moussala M, Fobi G, Ongolo Zogo P, Bella Hiag LA, Bengono G, McMoli TE. Retinal hemorrhages after ivermectin treatment for onchocerciasis in a patient with Loa loa microfilaremia. J Fr Ophtalmol. 2004;27(1):63–6. pmid:14968080
- 19. Jacobsen KH, Andress BC, Bhagwat EA, Bryant CA, Chandrapu VR, Desmonts CG, et al. A call for loiasis to be added to the WHO list of neglected tropical diseases. Lancet Infect Dis. 2022;22(10):e299–302. pmid:35500592
- 20. Thomson MC, Obsomer V, Kamgno J, Gardon J, Wanji S, Takougang I, et al. Mapping the distribution of Loa loa in Cameroon in support of the African Programme for Onchocerciasis Control. Filaria J. 2004;3(1):7. pmid:15298709
- 21. Macé JM, Boussinesq M, Ngoumou P, Enyegue Oye J, Koéranga A, Godin C. Country-wide rapid epidemiological mapping of onchocerciasis (REMO) in Cameroon. Ann Trop Med Parasitol. 1997;91(4):379–91. pmid:9290845
- 22. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560–72. pmid:12748199
- 23. Burton MJ, Ramke J, Marques AP, Bourne RRA, Congdon N, Jones I, et al. The Lancet Global Health Commission on Global Eye Health: vision beyond 2020. Lancet Glob Health. 2021;9(4):e489–551. pmid:33607016
- 24. Gardon J, Gardon-Wendel N, Demanga N, Kamgno J, Chippaux JP, Boussinesq M. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet. 1997;350(9070):18–22. pmid:9217715
- 25. Garner A. Pathology of ocular onchocerciasis: human and experimental. Trans R Soc Trop Med Hyg. 1976;70(5–6):374–7. pmid:841643
- 26. Mansour A, Rodriguez L, Mansour H, Yehia M, Battaglia Parodi M. Presumed Onchocerciasis Chorioretinitis Spilling over into North America, Europe and Middle East. Diagnostics (Basel). 2023;13(24):3626. pmid:38132210
- 27. Semba RD, Murphy RP, Newland HS, Awadzi K, Greene BM, Taylor HR. Longitudinal study of lesions of the posterior segment in onchocerciasis. Ophthalmology. 1990;97(10):1334–41. pmid:2243684
- 28. Fobi G, Mourou Mbina JR, Ozoh G, Kombila M, Agaya C, Olinga Olinga JM, et al. Onchocerciasis in the area of Lastourville, Gabon. Clinical and entomological aspects. Bull Soc Pathol Exot. 2006;99(4):269–71. pmid:17111977
- 29. Akue JP, Nkoghe D, Padilla C, Moussavou G, Moukana H, Mbou RA, et al. Epidemiology of concomitant infection due to Loa loa and Mansonella perstans in Gabon. PLoS Negl Trop Dis. 2011;5(10):e1329. pmid:22022623
- 30. Nana-Djeunga HC, Fossuo-Thotchum F, Pion SD, Chesnais CB, Kubofcik J, Mackenzie CD, et al. Loa loa Microfilariae in Skin Snips: Consequences for Onchocerciasis Monitoring and Evaluation in L. loa-Endemic Areas. Clin Infect Dis. 2019;69(9):1628–30. pmid:30861060
- 31. Bakri SJ, Bektas M, Sharp D, Luo R, Sarda SP, Khan S. Geographic atrophy: Mechanism of disease, pathophysiology, and role of the complement system. J Manag Care Spec Pharm. 2023;29(5-a Suppl):S2–11. pmid:37125931
- 32. Heesterbeek TJ, Lorés-Motta L, Hoyng CB, Lechanteur YTE, den Hollander AI. Risk factors for progression of age-related macular degeneration. Ophthalmic Physiol Opt. 2020;40(2):140–70. pmid:32100327
- 33. Takougang I, Meremikwu M, Wandji S, Yenshu EV, Aripko B, Lamlenn SB, et al. Rapid assessment method for prevalence and intensity of Loa loa infection. Bull World Health Organ. 2002;80(11):852–8. pmid:12481206
- 34. Kamtchum Tatuene J, Gounoue Fotsing R, Nkoa T, Tchateng Mbougua J, Nana Djeunga H, Bopda J. Epidemiology of Loa loa and Mansonella perstans filariasis in the Akonolinga health district, Centre Region, Cameroon. Health Sci Dis. 2014;15(1).
- 35. Fain A. Current problems of loaiasis. Bull World Health Organ. 1978;56(2):155–67. pmid:96952
- 36. Van Hoegaerden M, Chabaud B, Akue JP, Ivanoff B. Filariasis due to Loa loa and Mansonella perstans: distribution in the region of Okondja, Haut-Ogooué Province, Gabon, with parasitological and serological follow-up over one year. Trans R Soc Trop Med Hyg. 1987;81(3):441–6. pmid:3479854
- 37. Eberhard ML, Orihel TC. Loa loa: output of microfilariae in single pair infections. Trop Med Parasitol. 1986;37(4):369–74. pmid:3470872
- 38. Osuntokun O, Olurin O. Filarial worm (Loa loa) in the anterior chamber. Report of two cases. Br J Ophthalmol. 1975;59(3):166–7. pmid:1131358
- 39.
Kamgno J, Nana-Djeunga HC, Kouam-Kenmogne M. Loiasis. In: Gyapong JO, Boatin BA, Editors. Neglected tropical diseases - Sub-Saharan Africa. 2 ed. Cham: Springer Nature. 2024. p. 171–94.
- 40. M’Bondoukwé NP, Owono-Medang M, Moussavou-Boussougou MN, Akoue Y, Migueba V, Bulaev D, et al. Low diagnostic performance of thick blood smears of 50 µl in comparison with direct examination of 10 µl blood and the leukoconcentration technique of 5ml blood among loiasis-suspected patients with low microfilaremia in Gabon, Central Africa, using the STARD-BLCM guidelines. Parasit Vectors. 2024;17(1):138. pmid:38491557
- 41. Nana-Djeunga HC, Sicard CM, Mogoung-Wafo AE, Chesnais CB, Deleglise H, Touka-Nounkeu R, et al. Changes in Onchocerciasis Ov16 IgG4 Rapid Diagnostic Test Results Over One-Month Follow-up: Lessons for Reading Timeframe and Decision-Making. Am J Trop Med Hyg. 2022;107(3):658–61. Epub 2022/08/02. pmid:35914689; PMCID: PMC9490668.